In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Sensus Healthcare (SRTS – Research Report), with a price target of $8.00. The company’s shares closed yesterday at $3.10.
Vendetti covers the Healthcare sector, focusing on stocks such as Biolase, Icecure Medical, and Sientra. According to TipRanks, Vendetti has an average return of -2.3% and a 32.80% success rate on recommended stocks.
Sensus Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $8.00.
See today’s best-performing stocks on TipRanks >>
SRTS market cap is currently $44.6M and has a P/E ratio of 21.99.
Based on the recent corporate insider activity of 13 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SRTS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sensus Healthcare, Inc. engages in the design, manufacture, and marketing of proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions. Its main product is SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Read More on SRTS:
- Sensus Healthcare reports Q2 EPS (2c), consensus (8c)
- Sensus Healthcare Reports Second Quarter 2023 Financial Results
- Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
- Sensus Healthcare Completes Installation of its First SRT System in Ireland
- Sensus Healthcare completes installation of first SRT system in Ireland
